Novartis reported $29.81B in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Abbvie ABBV:US $ 32521M 2673M
Amgen AMGN:US $ 12886M 702M
AstraZeneca AZN:LN 22740M 146M
Astrazeneca AZN:US $ 22740M 146M
Biogen BIIB:US $ 3946.6M 351.6M
Bristol Myers Squibb BMY:US $ 22821M 953M
Canopy Growth Corp WEED:CN C$ 212.9M 26.35M
Catalent CTLT:US $ 1046M 1M
Corcept Therapeutics CORT:US $ 57.24M 9.7M
Eli Lilly And LLY:US $ 13386M 1666.7M
Endo International Ordinary Shares ENDP:US $ 1376.14M 253.82M
Gilead Sciences GILD:US $ 8558M 3052M
GlaxoSmithKline GSK:LN 24278M 608M
Glaxosmithkline GSK:US $ 24278M 608M
Horizon Pharma HZNP:US $ 825.18M 61.39M
JAZZ PHA JAZZ:US $ 737.41M 71.89M
Johnson & Johnson JNJ:US $ 43390M 1836M
Lannett LCI:US $ 94.36M 5.1M
Merk MRK:US $ 22316M 1556M
Novartis NOVN:VX SF 29807M 401M
Pacira Pharmaceuticals PCRX:US $ 305.07M 216.04M
Perrigo Ordinary Shares PRGO:US $ 981.3M 606.6M
Pfizer PFE:US $ 39268M 3403M
Phibro Animal Health PAHC:US $ 187.1M 20.47M
Prestige Brands PBH:US $ 143.42M 8.3M
Supernus Pharmaceuticals SUPN:US $ 284.56M 30.82M
Teva Pharmaceutical Industries TEVA:US $ 11613M 586M
Valeant Pharmaceuticals VRX:CN $ 4774M 424M
Zoetis ZTS:US $ 3034M 1237M